Intrinsic Value
AbbVie Inc. · ABBV
Conservative
More adverse but historically defensible assumptions.
$83.07
Base
The model's central intrinsic-value estimate.
$109.21
Optimistic
More favorable but historically defensible assumptions.
$201.27
Scenarios are the same model run under different but historically defensible assumptions. They are not price targets. Where a valuation gap is shown it is a comparison with a recent close, not a forecast return; where the price is stale, no gap is shown at all.
Model confidence: 66%Valuation as of Sep 21, 2026Latest filing used Feb 20, 2026
Confidence reflects data completeness, accounting quality, and model reliability. It is not a probability of future price.
Valuation drivers
- Normalized operating margin
- 28.0%
- Normalized NOPAT margin
- 21.8%
- Revenue growth
- 8.6%
- WACC
- 8.22%
- Terminal growth
- 2.50%
- Reinvestment method
- incremental roic
- Terminal-value share
- 76.3%
Model notes (3)
- Terminal value is 76% of enterprise value (Base case)
- Terminal value is 93% of enterprise value (Optimistic case)
- Preferred equity not reported
Model details
- Normalization
- V1
- Scenario
- V2
- Confidence
- V1
- Engine version
- valuation-1.0.1-share-units-terminal
- Data snapshot
- filed:2026-02-20